spanky
i'm too old to mess with biotechs very much any more, but they're the only place to be for big returns. the pure science, however, is not the best gauge of the best entry points...the likelihood for near term buyout is. acquisition candidates are where it's at.
as much as many here are turned off by the 'biotech values' board posters, check out the entries they select in the charity contest every year.
you could do very nicely with the portfolios of the regular contributors over there entered in that contest. just because most (one less than in years past, it seems) doubt PPHM's science, don't paint them all with the black brush.